Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxidative Heck Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel total synthesis of Buprenorphine via Heck reaction. Reduces cost and supply risk compared to poppy extraction. High ee value.
Patent CN114502560B details a novel total synthesis route for morphine derivatives. Achieve high yields and supply chain stability with our advanced pharmaceutical intermediates.
Patent CN115925677B reveals high-yield oxidative Heck reaction for thiophene sulfone olefin materials. Offers scalable supply chain solutions for display and optoelectronic manufacturing.
Patent CN109761810B details a solvent-free ball milling method for oxidative Heck coupling, offering high yields and rapid synthesis for pharmaceutical intermediates.
Patent CN109761810B reveals a solvent-free oxidative Heck reaction using mechanical grinding. This breakthrough enables high-yield synthesis of inactive olefin aryl compounds with significant cost and time reductions.
Patent CN114105875B reveals a total synthesis route for dihydroetorphine via Heck reaction. Offers cost reduction and supply stability for pharmaceutical manufacturing.
Patent CN114423764B reveals a biomimetic total synthesis route for morphine derivatives, offering high-purity intermediates and scalable manufacturing solutions for global pharmaceutical supply chains.
Patent CN110845363B details a Rh-catalyzed C-H activation route for o-alkenyl nitriles. Offers cost reduction in pharmaceutical intermediate manufacturing with high selectivity.
Patent CN109879792B details a Rh(III)-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharmaceutical intermediates manufacturing with improved atom economy.